Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer

Cancer Letters

Volumn 147, Issue 1-2, 1999, Pages 157-162

  Oki, Eiji ^a   Maehara, Yoshihiko ^a   Tokunaga, Eriko ^a   Kakeji, Yoshihiro ^b   Sugimachi, Keizo ^a,b  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

p53; Quantitative RT PCR; Real time PCR; Taqman probe; Tumor suppressor gene

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GASTROINTESTINAL CARCINOMA; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; BIOPSY; CELL CYCLE PROTEINS; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FLUORESCENT DYES; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0032758543     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00288-8     Document Type: Article

References (20)

1. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. p53 mutations in human cancers. Science. 253:1991;49-53.
2. Levine A.J., Momand J., Finlay C.A. The p53 tumour suppressor gene. Nature. 351:1991;453-456.
3. Haffner R., Oren M. Biochemical properties and biological effects of p53. Curr. Opin. Genet. Dev. 5:1995;84-90.
4. Garkavtsev I., Kazarov A., Gudkov A., Riabowol K. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nat. Genet. 14:1996;415-420.
5. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J.C., Valent A., Minty A., Chalon P., Lelias J.M., Dumont X., Ferrara P., McKeon F., Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 90:1997;809-819.
6. Jost C.A., Marin M.C., Kaelin W.G. Jr. p73 is a human p53-related protein that can induce apoptosis. Nature. 389:1997;191-194.
7. Helbing C.C., Veillette C., Riabowol K., Johnston R.N., Garkavtsev I. A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis. Cancer Res. 57:1997;1255-1258.
8. Garkavtsev I., Grigorian I.A., Ossovskaya V.S., Chernov M.V., Chumakov P.M., Gudkov A.V. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature. 391:1998;295-298.
9. Garkavtsev I., Riabowol K. Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor. Mol. Cell Biol. 17:1997;2014-2019.
10. Milner J. DNA damage, p53 and anticancer therapies. Nat. Med. 1:1995;879-880.
11. Weller M. Predicting response to cancer chemotherapy: the role of p53. Cell Tissue Res. 292:1998;435-445.
12. Beaudry G.A., Bertelsen A.H., Sherman M.I. Therapeutic targeting of the p53 tumor suppressor gene. Curr. Opin. Biotechnol. 7:1996;592-600.
13. Nielsen L.L., Maneval D.C. P53 tumor suppressor gene therapy for cancer. Cancer Gene Ther. 5:1998;52-63.
14. Holland P.M., Abramson R.D., Watson R., Gelfand D.H. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA. 88:1991;7276-7280.
15. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 6:1996;986-994.
16. Yamamoto M., Maehara Y., Oda S., Ichiyoshi Y., Kusumoto T., Sugimachi K. The p53 tumor suppressor gene in anticancer agent-induced apoptosis and chemosensitivity of human gastrointestinal cancer cell lines. Cancer Chemother. Pharm. 43:1999;43-49.
17. Mai M., Yokomizo A., Qian C., Yang P., Tindall D.J., Smith D.I., Liu W. Activation of p73 silent allele in lung cancer. Cancer Res. 58:1998;2347-2349.
18. Takahashi H., Ichimiya S., Nimura Y., Watanabe M., Furusato M., Wakui S., Yatani R., Aizawa S., Nakagawara A. Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. Cancer Res. 58:1998;2076-2077.
19. Casares S., Ionov Y., Ge H.Y., Stanbridge E., Perucho M. The microsatellite mutator phenotype of colon cancer cells is often recessive. Oncogene. 11:1995;2303-2310.
20. Cottu P.H., Muzeau F., Estreicher A., Flejou J.F., Iggo R., Thomas G., Hamelin R. Inverse correlation between RER+ status and p53 mutation in colorectal cancer cell lines. Oncogene. 13:1996;2727-2730.